Literature DB >> 8211355

Use of psychometric measures and nonorganic signs testing in detecting nomogenic disorders in low back pain patients.

B Hayes1, C A Solyom, P C Wing, J Berkowitz.   

Abstract

The effect of financial compensation on responses to psychometric testing was studied in 231 chronic back pain patients. Item by item comparison of responses to two tests, readministered within 4 hours, yielded inconsistency scores. These inconsistency scores, along with scores on other psychometric measures and on Waddell's nonorganic signs test, of a group of 97 patients anticipating or receiving financial compensation (AFC), and a group of 134 patients not receiving or anticipating financial compensation (non-AFC) were compared. The AFC group had significantly higher mean scores than did the non-AFC group on the inconsistency measures, on almost all psychometric tests and on nonorganic signs. Almost all non-AFC subjects scored "0" on nonorganics, whereas 83% of AFC subjects scored "2" or higher. Prediction analysis revealed that the nonorganics score alone can predict AFC/non-AFC status; 90% of subjects were correctly classified. The inconsistency scores correctly classified 78%. Together, they correctly classified 93%. It was concluded that nonorganic scores and inconsistency scores (as defined by the investigators) distinguish between, and can predict membership in AFC and non-AFC groups. The significantly higher inconsistency scores obtained by the AFC group suggest that these psychometric test results are unreliable and hence invalid for this group.

Entities:  

Mesh:

Year:  1993        PMID: 8211355     DOI: 10.1097/00007632-199308000-00002

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  1 in total

1.  When patients and surgeons disagree about surgical outcome: investigating patient factors and chart note communication.

Authors:  Carolyn E Schwartz; Armon Ayandeh; Joel A Finkelstein
Journal:  Health Qual Life Outcomes       Date:  2015-09-29       Impact factor: 3.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.